Posted inNew Drugs, Rare/Orphan Diseases, Regulatory Koselugo: First Drug to Treat Neurofibromatosis April 14, 2021September 8, 2022 Selumetinib by AstraZeneca powerfully suppresses tumor growth in neurofibromatosis type 1.
